TRV GP V
Latest statistics and disclosures from TRV GP V's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RAPP, SEPN, MAZE, and represent 100.00% of TRV GP V's stock portfolio.
- Reduced shares in these 1 stock: RAPP (-$36M).
- TRV GP V was a net seller of stock by $-36M.
- TRV GP V has $498M in assets under management (AUM), dropping by 24.25%.
- Central Index Key (CIK): 0001990717
Tip: Access up to 7 years of quarterly data
Positions held by TRV GP V consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for TRV GP V
TRV GP V holds 3 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rapport Therapeutics (RAPP) | 52.5 | $262M | -11% | 6.3M | 41.67 |
|
| Septerna (SEPN) | 41.8 | $208M | 6.2M | 33.49 |
|
|
| Maze Therapeatics (MAZE) | 5.7 | $28M | 951k | 29.84 |
|
Past Filings by TRV GP V
SEC 13F filings are viewable for TRV GP V going back to 2024
- TRV GP V 2026 Q2 filed Aug. 10, 2026
- TRV GP V 2026 Q1 filed May 7, 2026
- TRV GP V 2025 Q4 filed Feb. 13, 2026
- TRV GP V 2025 Q3 filed Nov. 13, 2025
- TRV GP V 2025 Q2 filed Aug. 8, 2025
- TRV GP V 2025 Q1 filed May 9, 2025
- TRV GP V 2024 Q4 filed Feb. 13, 2025